Zhang L,Wang F,Wang L,et al. Prevalence of chronic kidney disease in China:a cross-sectional survey [J]. Lancet,2012,379(9818):815.
[2]
Vidt D G. Inflammation in renal disease [J]. Am J Cardiol,2006,97(2A):20A.
[3]
Filiopoulos V,Vlassopoulos D. Inflammatory syndrome in chronic kidney disease:pathogenesis and influence on outcomes [J]. Inflamm Allergy Drug Targets,2009,8(5):369.
[4]
Stambe C,Nikolic-Paterson D J,Hill P A,et al. p38 mitogen-activated protein kinase activation and cell localization in human glomerulonephritis: correlation with renal injury [J]. J Am Soc Nephrol,2004,15(2):326.
[5]
Stambe C,Atkins R C,Tesch G H,et al. Blockade of p38alpha MAPK ameliorates acute inflammatory renal injury in rat anti-GBM glomerulonephritis [J]. J Am Soc Nephrol,2003,14(2):338.
Raij L,Azar S,Keane W. Mesangial immune injury,hypertension,and progressive glomerular damage in Dahl rats [J]. Kidney Int,1984,26(2):137.
[12]
Li L S,Liu Z H. Epidemiologic data of renal disease from a single unit in China:analysis based on 13,519 renal biopsies [J]. Kidney Int,2004,66(3):920.
Kiyomiya K,Matsuo S,Kurebe M. Mechanism of specific nuclear transport of adriamycin:the mode of nuclear translocation of adriamycin-proteasome complex [J]. Cancer Res,2001,61(6):2467.
[15]
Bertani T,Rocchi G,Sacchi G,et al. Adriamycin-induced glomerulosclerosis in the rat[J]. Am J Kidney Dis,1986,7(1):12.
[16]
Schieven G L. The p38alpha kinase plays a central role in inflammation[J]. Curr Top Med Chem,2009,9(11):1038.
[17]
Ono K,Han J. The p38 signal transduction pathway:activation and function [J]. Cell Signal,2000,12(1):1.
[18]
Park J M,Greten F R,Li Z W,et al. Macrophage apoptosis by anthrax lethal factor through p38 MAP kinase inhibition [J]. Science,2002,297(5589):2048.
Li J H,Campanale N V,Liang R J,et al. Inhibition of p38 mitogen-activated protein kinase and transforming growth factor-β1/Smad signaling pathways modulates the development of fibrosis in adriamycin-induced nephropathy [J]. Am J Pathol,2006,169(5):1527.
